[1]
“A Review: Oral Lumbrokinase as Potential Agent Prevents Myocardial Reinfarction Post-Reperfusion in ST-Elevation Myocardial Infarction (STEMI) Patients”, SCRIPTA SCORE Sci Med J., vol. 5, no. 2, pp. 121–131, Feb. 2024, doi: 10.32734/scripta.v5i2.15156.